Page last updated: 2024-08-16
pioglitazone and dihydrotestosterone
pioglitazone has been researched along with dihydrotestosterone in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, CS; Ku, CY; Pinzone, JJ; Ringel, MD; Shiau, CW; Wei, S; Yang, CC | 1 |
Adachi, S; Baba, T; Endo, T; Fujibe, Y; Honnma, H; Ikeda, K; Kiya, T; Kuno, Y; Morishita, M; Nagao, S; Saito, T | 1 |
Other Studies
2 other study(ies) available for pioglitazone and dihydrotestosterone
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Dihydrotestosterone; Humans; Male; Pioglitazone; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Thiazolidinediones; Transfection | 2006 |
Pioglitazone suppresses excessive follicular development in murine preantral follicles.
Topics: Androgens; Animals; Bone Morphogenetic Protein 2; Dihydrotestosterone; Estradiol; Female; Hypoglycemic Agents; Mice, Inbred ICR; Ovarian Follicle; Pioglitazone; Vascular Endothelial Growth Factor A | 2019 |